Cargando…

Towards optimal design of anti-malarial pharmacokinetic studies

BACKGROUND: Characterization of anti-malarial drug concentration profiles is necessary to optimize dosing, and thereby optimize cure rates and reduce both toxicity and the emergence of resistance. Population pharmacokinetic studies determine the drug concentration time profiles in the target patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simpson, Julie A, Jamsen, Kris M, Price, Ric N, White, Nicholas J, Lindegardh, Niklas, Tarning, Joel, Duffull, Stephen B
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732628/ https://www.ncbi.nlm.nih.gov/pubmed/19656413 http://dx.doi.org/10.1186/1475-2875-8-189

Ejemplares similares

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2011)

Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2012)

A robust design for identification of the Parasite Clearance Estimator
por: Jamsen, Kris M, et al.
Publicado: (2013)

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development
por: Zaloumis, Sophie, et al.
Publicado: (2012)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Ali, Shabana, et al.
Publicado: (2010)

Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014)

Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria
por: Adam, Ishag, et al.
Publicado: (2012)

Population Pharmacokinetic Assessment of the Effect of Food on Piperaquine Bioavailability in Patients with Uncomplicated Malaria
por: Tarning, Joel, et al.
Publicado: (2014)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan
por: Hoglund, Richard M, et al.
Publicado: (2012)

Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials
por: Combrinck, Jill M., et al.
Publicado: (2015)

Characterization and optimization of the haemozoin-like crystal (HLC) assay to determine Hz inhibiting effects of anti-malarial compounds
por: Tempera, Carolina, et al.
Publicado: (2015)

A framework for assessing the risk of resistance for anti-malarials in development
por: Ding, Xavier C, et al.
Publicado: (2012)

New molecular settings to support in vivo anti-malarial assays
por: Bahamontes-Rosa, Noemí, et al.
Publicado: (2016)

Statistical Power Calculations for Mixed Pharmacokinetic Study Designs Using a Population Approach
por: Kloprogge, Frank, et al.
Publicado: (2014)

Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry
por: Hanpithakpong, Warunee, et al.
Publicado: (2022)

The ACTwatch project: methods to describe anti-malarial markets in seven countries
por: Shewchuk, Tanya, et al.
Publicado: (2011)

Quantum dots: a new tool for anti-malarial drug assays
por: Ku, Min-Je, et al.
Publicado: (2011)

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

Grading fluorescein angiograms in malarial retinopathy
por: MacCormick, Ian J. C., et al.
Publicado: (2015)

Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges
por: Dahal, Prabin, et al.
Publicado: (2017)

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies
por: Corran, Patrick H, et al.
Publicado: (2008)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
por: Tarning, Joel, et al.
Publicado: (2012)

The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice
por: Abay, Efrem T, et al.
Publicado: (2014)

Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay
por: Rebelo, Maria, et al.
Publicado: (2015)

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market
por: O’Connell, Kathryn A, et al.
Publicado: (2013)

Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs
por: Tougan, Takahiro, et al.
Publicado: (2019)

Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations
por: Khalil, Insaf F, et al.
Publicado: (2011)

A simple and inexpensive haemozoin-based colorimetric method to evaluate anti-malarial drug activity
por: Men, Tran Thanh, et al.
Publicado: (2012)

Development of a genetic tool for functional screening of anti-malarial bioactive extracts in metagenomic libraries
por: Mongui, Alvaro, et al.
Publicado: (2015)

Predictive modeling of anti-malarial molecules inhibiting apicoplast formation
por: Jamal, Salma, et al.
Publicado: (2013)

Pill characterization data streams for reducing exposure to inadequately identified anti-malarial medication in developing countries
por: Pennefather, Peter, et al.
Publicado: (2010)

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study
por: Ozawa, Sachiko, et al.
Publicado: (2019)

The effect of varying analytical methods on estimates of anti-malarial clinical efficacy
por: Verret, Wendy J, et al.
Publicado: (2009)

Liquid chromatographic–mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria()
por: Sriboonvorakul, Natthida, et al.
Publicado: (2013)

Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations
por: Youdom, Solange Whegang, et al.
Publicado: (2012)

A lactate dehydrogenase ELISA-based assay for the in vitro determination of Plasmodium berghei sensitivity to anti-malarial drugs
por: Orjuela-Sánchez, Pamela, et al.
Publicado: (2012)

Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum
por: Smith-Aguasca, Rebecca, et al.
Publicado: (2019)

Nonlinear Mixed-Effects Modelling of In Vitro Drug Susceptibility and Molecular Correlates of Multidrug Resistant Plasmodium falciparum
por: Simpson, Julie A., et al.
Publicado: (2013)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects
por: McGready, Rose, et al.
Publicado: (2012)

Automated and unsupervised detection of malarial parasites in microscopic images
por: Purwar, Yashasvi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vb4ndq2p66fehrq3q3k5s0r0ma